Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Multiple Myeloma 36Recurrence 9Neoplasms, Plasma Cell 5Neoplasms 3Lymphoma, Non-Hodgkin 2Immunoglobulin Light-chain Amyloidosis 2Hematologic Neoplasms 2Hematologic Diseases 2Blood Protein Disorders 2Thrombocythemia, Essential 1Sarcoma, Kaposi 1Proteostasis Deficiencies 1Primary Myelofibrosis 1Polycythemia Vera 1Paraproteinemias 1Pancreatic Neoplasms 1Neoplasms by Histologic Type 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Primary Effusion 1Leukemia, Myeloid, Acute 1Hypoxia 1Hodgkin Disease 1Corneal Diseases 1Carcinoma, Small Cell 1

Interventions

ruxolitinib 9Peripheral Blood Stem Cell Transplantation 6Azacitidine 5Methotrexate 4Busulfan 4fludarabine phosphate 3Cyclosporine 3Whole-Body Irradiation 2Tacrolimus 2Mycophenolic Acid 2Cytarabine 2Antilymphocyte Serum 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2venetoclax 1vatalanib 1tagraxofusp 1sonidegib 1rucaparib 1pomalidomide 1pevonedistat 1pelcitoclax 1lestaurtinib 1givinostat hydrochloride 1givinostat 1fedratinib 1ethanolamine oleate 1axatilimab 1abiraterone 1Vitamin E 1Trimethoprim, Sulfamethoxazole Drug Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Primary Myelofibrosis × pomalidomide × Clear all
NCT00669578 2019-12-30

CC-4047 in Treating Patients With Myelofibrosis

Mayo Clinic

Phase 1/2 Completed
77 enrolled 9 charts
Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡